A Pilot Assessment of Caregivers’ and Patients’ Perception of Naloxone Coprescribing in a Pediatric Sickle Cell Population
There is a lack of awareness about naloxone in the pediatric sickle cell disease population. Those who were aware of naloxone did feel it was an important medication and appeared to have a positive view of it.
Authors
- Lewis L. Hsu (ORCID: https://orcid.org/0000-0002-3156-2378)
- Paige Reilly
- Lauren M. Oliveri
- Leslie Briars (ORCID: https://orcid.org/0000-0002-3240-4646)
- Sara W. Hovey (ORCID: https://orcid.org/0000-0002-7350-4176)
- Elizabeth B. Ferengul
Institutions
- University of Illinois Chicago (US)
Publication Details
- Journal
- The Journal of Pediatric Pharmacology and Therapeutics
- Published
- 2025-08-01
- DOI
- https://doi.org/10.5863/jppt-24-00071
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00